Page last updated: 2024-08-22

angiotensin ii and atenolol

angiotensin ii has been researched along with atenolol in 52 studies

Research

Studies (52)

Timeframe	Studies, this research(%)	All Research%
pre-1990	13 (25.00)	18.7374
1990's	12 (23.08)	18.2507
2000's	19 (36.54)	29.6817
2010's	8 (15.38)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E	1
Wilcox, RG	1
Giese, J; Ibsen, H; Leth, A; McNair, A	1
Barjon, P; Deschodt, G; Fourcade, J; Mimran, A	1
Dzau, VJ; Stevenson, L; Tang, SS	1
Blantz, RC; Mundy, CA; Tucker, BJ	1
Cadnapaphornchai, P; Kellner, D; McDonald, FD	1
Majewski, H; Rump, LC	1
Bune, AJ; Cain, MD; Chalmers, JP; Morris, MJ; Russell, AE; Southgate, DO; West, MJ; Wing, LM	1
Bune, AJ; Chalmers, JP; Elliott, JM; Morris, MJ; Russell, AE; West, MJ; Wing, LM	1
Barney, CC; Katovich, MJ	1
Jones, DL	1
Creek, RD; Katholi, RE; McCann, WP	1
Birkenhäger, WH; de Leeuw, PW; van Soest, GA	1
Freslon, JL; Giudicelli, JF; Glasson, S; Richer, C	1
Dunlay, MC; Goldberg, AI; Sweet, CS	1
Hajj-Ali, AF; Wong, PC	1
Hilgenfeldt, U; Schwind, S	1
Inada, Y; Kanagawa, R; Nishikawa, K; Ojima, M; Sanada, T; Wada, T	1
Dahlöf, B; de Faire, U; Devereux, R; Fyhrquist, F; Hedner, T; Ibsen, H; Julius, S; Kjeldsen, S; Kristianson, K; Lederballe-Pedersen, O; Lindholm, LH; Nieminen, MS; Omvik, P; Oparil, S; Wedel, H	1
Czendlik, CH; Howald, H; Preiswerk, G; Sioufi, A	1
Henegar, JR; Janicki, JS; Schwartz, DD	1
Harder, S; Kenedi, P; Rietbrock, N; Schmidt, A; Thürmann, PA	1
Thürmann, PA	1
Gottdiener, JS	1
Alesse, E; Bravi, MC; Desideri, G; Ferri, C; Gulino, A; Martinotti, S; Pastore, L; Santucci, A; Tessitore, A; Toniato, E	1
Abernethy, DR; Andrawis, NS; Battle, MM; Burghart, PH; Klamerus, KJ; Mayer, P; Neefe, L; Weinryb, I	1
Crow, MT; Gluzband, YA; Janicki, JS; Kass, DA; Lindsey, ML; Paolocci, N; Senzaki, H	1
Baiz, AQ; Bortman, G; Farsang, C; Garcia-Puig, J; Niegowska, J; Vrijens, F	1
Head, GA; Minami, N	1
Ball, KJ; Stumpe, KO; Williams, PA	1
Enzminger, H; Lemmer, B; Witte, K	1
Kahan, T; Nilsson, P	1
Malik, RA	1
Ariff, B; Augst, A; Barratt, D; Glor, F; Hughes, A; Poulter, N; Sever, P; Stanton, A; Thom, SA; Xu, Y	1
de Boer, RA; Gans, RO; Gansevoort, RT; van Veldhuisen, DJ	1
Sidorenko, BA; Ugriumova, MO	1
Arend, A; Aunapuu, M; Ots, M; Pechter, U; Suuroja, T	1
Ferrario, CM; Gallagher, PE; Geary, RL; Igase, M; Strawn, WB	1
Asai, T; Fujita, H; Kanmatsuse, K; Kushiro, T	1
Averill, DB; Brosnihan, KB; Ferrario, CM; Schiffrin, EL; Smith, RD; Yokoyama, H	1
Savoia, C; Schiffrin, EL; Touyz, RM; Volpe, M	1
Feihl, F; Gojanovic, B; Liaudet, L; Waeber, B	1
Campanelli, JJ; Christensen, LP; Dedkov, EI; Tomanek, RJ; Weiss, RM; Zhang, RL; Zheng, W	1
Castania, JA; Durand, Mde T; Fazan, R; Salgado, HC; Salgado, MC	1
Huang, Y; Shan, Z; Wang, C; Wang, Q; Yan, K; Yan, W; Zhang, Y	1
Hattori, Y; Hayashi, T; Kuzuya, M; Maeda, M; Sakakibara, Y; Taguchi, K; Yamaguchi, T	1
Anhê, GF; Antunes, E; Calmasini, F; Faria, Jde A; Mónica, FZ; Moscoso, JA; Ramos-Filho, AC	1
Al-Abassi, FA; Al-Alsieni, AI; Anwar, F; Bacha, AO; Hejazi, MM; Kaleemuddin, M; Kazmi, I	1
Niu, M; Shi, R; Wang, Y; Yin, S; Zhang, F	1
Bailey, KR; Beitelshees, AL; Boerwinkle, E; Chapman, AB; Cooper-DeHoff, RM; Gong, Y; Gums, JG; Johnson, JA; Langaee, TY; McDonough, CW; Scherer, S; Shahin, MH; Singh, S; Turner, ST; Wang, Z	1

Reviews

3 review(s) available for angiotensin ii and atenolol

Article	Year
[Results from the LIFE study: promising effects of new hypertensive agents]. Lakartidningen, 2002, Apr-18, Volume: 99, Issue:16 Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Antihypertensive Agents; Atenolol; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome	2002
[New perspectives of the use of angiotensin II receptor blocker]. Kardiologiia, 2003, Volume: 43, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Diabetes Mellitus; Humans; Hypertension; Hypertrophy, Left Ventricular; Hyperuricemia; Losartan; Receptors, Angiotensin	2003
Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2008, Volume: 9, Issue:1 Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Calcium Channel Blockers; Drug Combinations; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hypertension; Indoles; Middle Aged; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Sympathetic Nervous System; Verapamil	2008

Trials

14 trial(s) available for angiotensin ii and atenolol

Article	Year
Combination hypotensive therapy with atenolol, bendrofluazide and hydrallazine. Postgraduate medical journal, 1977, Volume: 53 Suppl 3 Topics: Angiotensin II; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Propanolamines; Renin	1977
Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol: contrasts in hypotensive interactions. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1987, Volume: 5, Issue:5 Topics: Angiotensin II; Atenolol; Atrial Natriuretic Factor; Double-Blind Method; Drug Therapy, Combination; Enalapril; Factor Analysis, Statistical; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Random Allocation; Renin	1987
Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension. The American journal of cardiology, 1995, Apr-15, Volume: 75, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Asthenia; Atenolol; Biphenyl Compounds; Cough; Dizziness; Double-Blind Method; Fatigue; Felodipine; Female; Headache; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Placebos; Respiratory Tract Infections; Safety; Tetrazoles	1995
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. American journal of hypertension, 1997, Volume: 10, Issue:7 Pt 1 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Losartan; Male; Middle Aged; Research Design; Tetrazoles; Treatment Outcome	1997
Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol. European journal of clinical pharmacology, 1997, Volume: 52, Issue:6 Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Antihypertensive Agents; Area Under Curve; Atenolol; Blood Pressure; Cross-Over Studies; Drug Interactions; Exercise; Half-Life; Heart Rate; Humans; Male; Metabolic Clearance Rate; Renin; Tetrazoles; Valine; Valsartan	1997
Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension. Circulation, 1998, Nov-10, Volume: 98, Issue:19 Topics: Angiotensin II; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Tetrazoles; Treatment Outcome; Valine; Valsartan	1998
Angiotensin II antagonism and the heart: valsartan in left ventricular hypertrophy. Journal of cardiovascular pharmacology, 1999, Volume: 33 Suppl 1 Topics: Angiotensin II; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertrophy, Left Ventricular; Male; Middle Aged; Tetrazoles; Valine; Valsartan	1999
Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension. Circulation, 1999, Aug-10, Volume: 100, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Diuretics; Drug Interactions; Heart Ventricles; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Organ Size; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Research Design; Tetrazoles; Valine; Valsartan	1999
A pharmacokinetic and pharmacodynamic study of the potential drug interaction between tasosartan and atenolol in patients with stage 1 and 2 essential hypertension. Journal of clinical pharmacology, 2000, Volume: 40, Issue:3 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Atenolol; Drug Synergism; Humans; Hypertension; Middle Aged; Pyrimidines; Single-Blind Method; Tetrazoles	2000
The efficacy and tolerability of losartan versus atenolol in patients with isolated systolic hypertension. Losartan ISH Investigators Group. Journal of hypertension, 2000, Volume: 18, Issue:6 Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Systole; Treatment Outcome	2000
Prevention of cardiovascular morbidity with angiotension receptor blockade: life after LIFE. Diabetic medicine : a journal of the British Diabetic Association, 2002, Volume: 19 Suppl 5 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Atenolol; Clinical Protocols; Diabetes Complications; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Morbidity; Risk	2002
Comparison of the effects of antihypertensive treatment with angiotensin II blockade and beta-blockade on carotid wall structure and haemodynamics: protocol and baseline demographics. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2002, Volume: 3, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin II; Antihypertensive Agents; Arteriosclerosis; Atenolol; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carotid Artery, Common; Cerebrovascular Circulation; Double-Blind Method; Female; Humans; Image Processing, Computer-Assisted; Laser-Doppler Flowmetry; Male; Manometry; Middle Aged; Models, Cardiovascular; Tetrazoles; Ultrasonography	2002
Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. Hypertension (Dallas, Tex. : 1979), 2007, Volume: 49, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arteries; Atenolol; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Receptor, Angiotensin, Type 2; Tetrazoles; Valine; Valsartan; Vascular Resistance; Vasodilation	2007
Tagging SNPs in REN, AGTR1 and AGTR2 genes and response of renin activity, angiotensin II and aldosterone concentrations to antihypertensive treatment in Kazakans. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2011, Volume: 12, Issue:4 Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; China; Double-Blind Method; Ethnicity; Female; Genetic Association Studies; Humans; Hypertension; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin	2011

Other Studies

35 other study(ies) available for angiotensin ii and atenolol

Article	Year
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH Bioorganic & medicinal chemistry, 2017, 01-15, Volume: 25, Issue:2 Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship	2017
Angiotensin II blockade during combined thiazide-beta-adrenoreceptor-blocker treatment. Clinical science (London, England : 1979), 1979, Volume: 57 Suppl 5 Topics: Adult; Angiotensin II; Atenolol; Blood Pressure; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Metoprolol; Plasma Volume; Propanolamines; Propranolol; Renin; Saralasin; Sodium	1979
The renin-angiotensin system and the antihypertensive effect of atenolol in man. Archives internationales de pharmacodynamie et de therapie, 1979, Volume: 241, Issue:1 Topics: Adult; Angiotensin II; Antihypertensive Agents; Atenolol; Female; Humans; Hypertension; Male; Middle Aged; Propanolamines; Renin; Saralasin	1979
Endothelial renin-angiotensin pathway. Adrenergic regulation of angiotensin secretion. Circulation research, 1990, Volume: 66, Issue:1 Topics: Angiotensin I; Angiotensin II; Angiotensin III; Animals; Atenolol; Captopril; Cattle; Cells, Cultured; Chromatography, High Pressure Liquid; Culture Media; Endothelium, Vascular; Isoproterenol; Phenylephrine; Propanolamines; Radioimmunoassay; Receptors, Adrenergic, beta; Renin-Angiotensin System	1990
Effects of beta 1-adrenergic blockade on glomerular dynamics and angiotensin II response. The American journal of physiology, 1989, Volume: 257, Issue:2 Pt 2 Topics: Angiotensin II; Animals; Atenolol; Blood Pressure; Glomerular Filtration Rate; Kidney Glomerulus; Pulse; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Reference Values	1989
Role of adrenoceptors in diphenylhydantoin-stimulated renin release. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1989, Volume: 190, Issue:4 Topics: Angiotensin II; Animals; Atenolol; Dogs; Female; Infusions, Intra-Arterial; Metoprolol; Phenytoin; Propanolamines; Receptors, Adrenergic; Renin	1989
Beta adrenoceptor facilitation of norepinephrine release is not dependent on local angiotensin II formation in the rat isolated kidney. The Journal of pharmacology and experimental therapeutics, 1987, Volume: 243, Issue:3 Topics: Angiotensin II; Animals; Atenolol; Captopril; In Vitro Techniques; Isoproterenol; Kidney; Male; Norepinephrine; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Saralasin	1987
Enalapril and atenolol in essential hypertension: attenuation of hypotensive effects in combination. Clinical and experimental hypertension. Part A, Theory and practice, 1988, Volume: 10, Issue:1 Topics: Aldosterone; Angiotensin II; Atenolol; Atrial Natriuretic Factor; Drug Interactions; Drug Therapy, Combination; Enalapril; Heart Rate; Humans; Hypertension; Peptidyl-Dipeptidase A; Renin	1988
Effect of beta-adrenergic antagonists on experimentally induced drinking in female rats. Pharmacology, biochemistry, and behavior, 1985, Volume: 22, Issue:4 Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Atenolol; Butoxamine; Drinking; Female; Hypertonic Solutions; Propranolol; Rats; Rats, Inbred Strains; Sodium Chloride; Stereoisomerism; Water Deprivation	1985
Hypothalamic alpha-adrenergic blockade modifies drinking and blood pressure responses to central angiotensin II in conscious rats. Canadian journal of physiology and pharmacology, 1988, Volume: 66, Issue:10 Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Atenolol; Blood Pressure; Cerebral Ventricles; Drinking Behavior; Hippocampus; Injections, Intraventricular; Male; Phentolamine; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Reference Values; Yohimbine	1988
Endogenous intrarenal adenosine preserves renal blood flow in one-kidney, one clip rats. Hypertension (Dallas, Tex. : 1979), 1988, Volume: 11, Issue:6 Pt 2 Topics: Adenosine; Angiotensin II; Animals; Atenolol; Blood Pressure; Hypertension, Renovascular; Male; Rats; Rats, Inbred Strains; Renal Circulation; Saralasin; Theophylline; Vascular Resistance	1988
Aldosterone response to antihypertensive treatment. Clinical and experimental hypertension. Part A, Theory and practice, 1982, Volume: 4, Issue:9-10 Topics: Adult; Aged; Aldosterone; Angiotensin II; Antihypertensive Agents; Atenolol; Blood Pressure; Dipeptides; Enalapril; Ethanolamines; Humans; Hypertension; Middle Aged; Prazosin; Pyridazines; Renin; Renin-Angiotensin System; Vasodilator Agents; Verapamil	1982
Captopril and hypertension development in the SHR. Clinical and experimental hypertension, 1980, Volume: 2, Issue:6 Topics: Angiotensin II; Animals; Atenolol; Blood Pressure; Captopril; Dihydralazine; Hypertension; Male; Proline; Rats; Rats, Inbred Strains; Sympathetic Nervous System; Vascular Resistance	1980
Beta adrenoceptor blockade in rabbit inhibits the renin-releasing effect of AT1 receptor antagonist losartan. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:3 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atenolol; Biphenyl Compounds; Blood Pressure; Heart Rate; Imidazoles; Indomethacin; Losartan; Male; Rabbits; Renin; Tetrazoles	1993
Angiotensin II is the mediator of the increase in hepatic angiotensinogen synthesis after bilateral nephrectomy. The American journal of physiology, 1993, Volume: 265, Issue:3 Pt 1 Topics: Adrenalectomy; Angiotensin II; Angiotensinogen; Animals; Atenolol; Biphenyl Compounds; Imidazoles; Kidney; Liver; Losartan; Male; Nephrectomy; Osmolar Concentration; Postoperative Period; Rats; Rats, Wistar; Renin; Tetrazoles; Time Factors	1993
Combined effects of the angiotensin II antagonist candesartan cilexetil (TCV-116) and other classes of antihypertensive drugs in spontaneously hypertensive rats. Hypertension research : official journal of the Japanese Society of Hypertension, 1996, Volume: 19, Issue:4 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Dihydropyridines; Diuretics; Drug Therapy, Combination; Hydrochlorothiazide; Male; Nitrobenzenes; Piperazines; Prazosin; Rats; Rats, Inbred SHR; Renin; Sodium Chloride Symporter Inhibitors; Tetrazoles	1996
ANG II-related myocardial damage: role of cardiac sympathetic catecholamines and beta-receptor regulation. The American journal of physiology, 1998, Volume: 275, Issue:2 Topics: Adrenal Medulla; Adrenergic beta-Antagonists; Angiotensin II; Animals; Atenolol; Catecholamines; Down-Regulation; Heart; Infusions, Intravenous; Male; Myocardium; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Sympathectomy; Sympathetic Nervous System; Time Factors	1998
Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation, 1999, Oct-12, Volume: 100, Issue:15 Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Cells, Cultured; Endothelium, Vascular; Female; Gene Expression Regulation; Humans; Hypertension; Intercellular Adhesion Molecule-1; Losartan; Male; Middle Aged; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Umbilical Veins	1999
beta-blockade prevents sustained metalloproteinase activation and diastolic stiffening induced by angiotensin II combined with evolving cardiac dysfunction. Circulation research, 2000, Apr-14, Volume: 86, Issue:7 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angiotensin II; Animals; Atenolol; Diastole; Dogs; Enzyme Activation; Female; Heart; Hemodynamics; Isoproterenol; Male; Metalloendopeptidases; Myocardial Contraction; Myocardium; Receptors, Adrenergic, beta; Systole; Tachycardia; Ventricular Function, Left	2000
Cardiac vagal responsiveness during development in spontaneously hypertensive rats. Autonomic neuroscience : basic & clinical, 2000, Aug-14, Volume: 82, Issue:3 Topics: Adrenergic beta-Antagonists; Age Factors; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atenolol; Baroreflex; Bradycardia; Electric Stimulation; Heart; Heart Rate; Hypertension; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Respiration; Respiration, Artificial; Vagus Nerve	2000
Relative efficacy of an angiotensin II antagonist compared with other antihypertensive agents. Olmesartan medoxomil versus antihypertensives. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 2001, Volume: 19, Issue:1 Topics: Angiotensin II; Antihypertensive Agents; Atenolol; Captopril; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypertension; Imidazoles; Losartan; Multicenter Studies as Topic; Olmesartan Medoxomil; Randomized Controlled Trials as Topic; Tetrazoles	2001
Altered melatonin production in TGR(mREN2)27 rats: on the regulation by adrenergic agonists, antagonists and angiotensin II in cultured pinealocytes. Journal of pineal research, 2001, Volume: 31, Issue:3 Topics: Adrenergic Agonists; Adrenergic Antagonists; Angiotensin II; Animals; Animals, Genetically Modified; Atenolol; Cells, Cultured; Dose-Response Relationship, Drug; Isoproterenol; Male; Melatonin; Norepinephrine; Pineal Gland; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System	2001
No morbidity-mortality. Commentary. Diabetic medicine : a journal of the British Diabetic Association, 2002, Volume: 19 Suppl 5 Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Atenolol; Diabetes Complications; Diabetes Mellitus; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Middle Aged; Morbidity; Patient Selection	2002
[Treatment of hypertension: angiotensin-II antagonists potentially better than beta-blockers in the occurrence of cardiovascular and cerebrovascular damage; the LIFE study in perspective]. Nederlands tijdschrift voor geneeskunde, 2003, Jan-18, Volume: 147, Issue:3 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Cerebrovascular Disorders; Humans; Hypertension; Losartan; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Treatment Outcome	2003
Ultrastructural changes in the remnant kidney (after 5/6 nephrectomy) glomerulus after losartan and atenolol treatment. Medicina (Kaunas, Lithuania), 2003, Volume: 39, Issue:10 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atenolol; Basement Membrane; Disease Models, Animal; Glomerulosclerosis, Focal Segmental; Hypertrophy; Kidney Failure, Chronic; Kidney Glomerulus; Losartan; Male; Microscopy, Electron; Nephrectomy; Proteinuria; Rats; Rats, Wistar; Systole; Time Factors	2003
Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats. American journal of physiology. Heart and circulatory physiology, 2005, Volume: 289, Issue:3 Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Aorta, Thoracic; Atenolol; Carboxypeptidases; Carotid Arteries; Gene Expression Regulation, Enzymologic; Hydralazine; Hypertension; Imidazoles; Male; Olmesartan Medoxomil; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles; Vasodilator Agents	2005
Different effects on inhibition of cardiac hypertrophy in spontaneously hypertensive rats by monotherapy and combination therapy of adrenergic receptor antagonists and/or the angiotensin II type 1 receptor blocker under comparable blood pressure reduction Hypertension research : official journal of the Japanese Society of Hypertension, 2005, Volume: 28, Issue:1 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atenolol; Blood Pressure; Cardiomegaly; Doxazosin; Drug Therapy, Combination; Echocardiography; Heart Rate; Hypertension; Losartan; Male; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; RNA, Messenger	2005
Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy. American journal of hypertension, 2005, Volume: 18, Issue:7 Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiomegaly; Collagen; Disease Progression; Endothelium, Vascular; Heart Rate; Hypertension; Imidazoles; Male; Mesenteric Arteries; Myocardium; Rats; Rats, Inbred SHR; Tetrazoles; Vascular Diseases; Vascular Resistance	2005
Postmyocardial infarction remodeling and coronary reserve: effects of ivabradine and beta blockade therapy. American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:1 Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Atenolol; Benzazepines; Bradykinin; Cardiotonic Agents; Collagen; Coronary Circulation; Electrocardiography; Heart Rate; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Ivabradine; Male; Myocardial Infarction; Neovascularization, Physiologic; Organ Size; Perfusion; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Ventricular Remodeling	2009
Hemodynamic responses to aortic depressor nerve stimulation in conscious L-NAME-induced hypertensive rats. American journal of physiology. Regulatory, integrative and comparative physiology, 2011, Volume: 300, Issue:2 Topics: Angiotensin II; Animals; Aorta; Atenolol; Atropine Derivatives; Baroreflex; Blood Pressure; Electric Stimulation; Heart Rate; Hemodynamics; Hypertension; Male; NG-Nitroarginine Methyl Ester; Parasympatholytics; Prazosin; Rats; Rats, Wistar	2011
eNOS-dependent antisenscence effect of a calcium channel blocker in human endothelial cells. PloS one, 2014, Volume: 9, Issue:2 Topics: Angiotensin II; Antihypertensive Agents; Atenolol; beta-Galactosidase; Calcium Channel Blockers; Cellular Senescence; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Lipoproteins, LDL; Nifedipine; Nitric Oxide Synthase Type III; Perindopril; Reactive Oxygen Species	2014
Blockade of renin-angiotensin system prevents micturition dysfunction in renovascular hypertensive rats. European journal of pharmacology, 2014, Sep-05, Volume: 738 Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Body Weight; Captopril; Cyclic AMP; Electric Stimulation; Female; Hypertension, Renovascular; Losartan; Male; Muscle Relaxation; Rats; Renin-Angiotensin System; Urethra; Urinary Bladder; Urination	2014
Alteration of serum immunoglobins, C-reactive protein, vitamin D, and electrolyte by atenolol and amlodipine in stress-induced hypertensive rats. Molecular and cellular biochemistry, 2018, Volume: 445, Issue:1-2 Topics: Amlodipine; Angiotensin II; Animals; Antihypertensive Agents; Atenolol; C-Reactive Protein; Calcium; Electrolytes; Female; Hypertension; Immunoglobulin G; Immunoglobulin M; Male; Potassium; Rats, Wistar; Sodium; Stress, Physiological; Vitamin D	2018
Nephroprotective effects of nebivolol in 2K1C rats through regulation of the kidney ROS-ADMA-NO pathway. Pharmacological reports : PR, 2018, Volume: 70, Issue:5 Topics: Amidohydrolases; Angiotensin II; Animals; Arginine; Atenolol; Blood Pressure; Hypertension, Renovascular; Kidney; Kidney Function Tests; Male; NADPH Oxidases; Nebivolol; Nitric Oxide; Nitric Oxide Synthase; Protective Agents; Protein-Arginine N-Methyltransferases; Rats; Reactive Oxygen Species; Signal Transduction	2018
Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazide. Pharmacogenetics and genomics, 2018, Volume: 28, Issue:11 Topics: Adult; Angiotensin II; Antihypertensive Agents; Atenolol; Bestrophins; Blood Pressure; Female; Genetic Association Studies; Humans; Hypertension; Male; Middle Aged; Muscle Proteins; Polymorphism, Single Nucleotide; Sodium Chloride Symporter Inhibitors	2018